Pharmaceutical companies looking for fresh sources of profit are increasingly investing in a range of health care innovations that aren’t drugs at all, from smartphone apps and educational websites to social media platforms and…
From October 2010 to February 2011, biotech Clinical Data’s stock doubled, mostly thanks to FDA approval of its novel antidepressant. But also pushing the stock up — and making it likely to perhaps double again — is speculati…
Companies that have piled up cash over the past few years are finding one good use for it: Repurchasing their own shares. January alone saw $57 billion in buybacks, compared with $357 billion for all of 2010. While buybacks don…
Pfizer’s cancer drug Sutent and Novartis’s drug Afinitor have both been found to be effective against the rare form of pancreatic cancer that Apple CEO Steve Jobs was diagnosed with in 2004, according to two studies published i…
Wall Street shrugged off instability in Egypt to rally to a two-and-a-half year high Tuesday, boosted by encouraging economic data and better-than-expected corporate earnings.
Continue reading Dow Closes Above …